Fagron Gmbh
Overview
Fagron Gmbh is a pharmaceutical company headquartered in Glinde, Germany, with 1,001-5,000 employees.
FDA compliance signals
24 FDA enforcement records linked to this company.
- recall — Class II2023-12-27
Labeling: Label Error on Declared Strength: Assay value on the label is incorrect.
- recall — Class II2023-12-27
Labeling: Label Error on Declared Strength: Assay value on the label is incorrect.
- recall — Class II2023-12-27
Labeling: Label Error on Declared Strength: Assay value on the label is incorrect.
- recall — Class II2023-12-27
Labeling: Label Error on Declared Strength: Assay value on the label is incorrect.
- warning_letter2022-06-14
FDA Warning Letter (drug product)
- recall — Class III2022-05-18
Subpotent Drug
- recall — Class III2022-05-18
Subpotent Drug
- recall — Class III2022-05-18
Subpotent Drug
- recall — Class III2022-05-18
Subpotent Drug
- recall — Class III2022-05-18
Subpotent Drug
- recall — Class I2022-05-18
Microbial Contamination of Non-Sterile Product: Product is contaminated with Burkholderia gladioli.
- recall — Class II2019-12-11
Microbial contamination of non-sterile product.
- warning_letter2018-08-29
FDA Warning Letter (drug product)
- recall — Class II2018-03-07
Microbial contamination of Non-Sterile Product; product contamination with yeast and mold (Paecilomyces saturatus and Aspergillus fumigatus).
- recall — Class II2017-11-22
cGMP Deviations: lack of quality assurance at the API manufacturer.
Is this Fagron Gmbh? Get in front of buyers actively sourcing.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Related companies
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.